Terms: = Chronic Myelogenous Leukemia AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
505 results:
1. A Rare Case of X-Linked Four-Way Philadelphia Chromosome Translocation with Therapeutic Challenges and Clonal Evolution.
Park SE; Lee JK; Kang HJ; Hong YJ; Oh AC; Kim H
Clin Lab; 2024 Sep; 70(9):. PubMed ID: 39257124
[TBL] [Abstract] [Full Text] [Related]
2. Gene Variants in Components of the microRNA Processing Pathway in chronic Myeloid leukemia.
Chavaro-Francisco G; Hernández-Zavala A; Bravo-Cidro CE; Rios-Rodriguez S; Muciño-Sánchez M; López-López M; Castro-Martínez XH; Olarte-Carrillo I; Garcia-Laguna A; Barranco-Lampón G; De la Cruz-Rosas A; Martínez-Tovar A; Córdova EJ
Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202414
[TBL] [Abstract] [Full Text] [Related]
3. ETV6::abl1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate.
Chen F
Ann Hematol; 2024 Sep; 103(9):3801-3804. PubMed ID: 38992279
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Factors and Clinical Outcomes in Patients with Blast Phase chronic Myeloid leukemia.
Huang J; Guan H
Clin Lab; 2024 Jul; 70(7):. PubMed ID: 38965952
[TBL] [Abstract] [Full Text] [Related]
5. Titania-Graphene Oxide Nanocomposite-Based Philadelphia-Positive leukemia Therapy.
Batool M; Qazi RE; Mudassir MA; Sajid Z; Zaman R; Rauf MA; Kousar S; Ahmad I; Rehman FU; Mian AA
ACS Appl Bio Mater; 2024 Jul; 7(7):4352-4365. PubMed ID: 38900491
[TBL] [Abstract] [Full Text] [Related]
6. Combination of an aurora kinase inhibitor and the abl tyrosine kinase inhibitor asciminib against abl inhibitor-resistant CML cells.
Okabe S; Moriyama M; Gotoh A
Med Oncol; 2024 May; 41(6):142. PubMed ID: 38714583
[TBL] [Abstract] [Full Text] [Related]
7. The Screening of microRNAs in chronic Myeloid leukemia: A Clinical Evaluation.
Wosniaki DK; Marin AM; Oliveira RN; Koerich GM; Munhoz EC; Farias JSH; Beltrame MP; Zanette DL; Aoki MN
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542337
[TBL] [Abstract] [Full Text] [Related]
8. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Factors in Philadelphia Chromosome-Positive Acute Myeloid leukemia Using Fluorescence in Situ Hybridization.
Zhang Z; Sun C; Cai L; Chen Y; Zhou X; Chen S; Feng X; Yang X; Li Q; Liu L; Zhou H; Li B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345995
[TBL] [Abstract] [Full Text] [Related]
10. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
Shin JE; Kim SH; Kong M; Kim HR; Yoon S; Kee KM; Kim JA; Kim DH; Park SY; Park JH; Kim H; No KT; Lee HW; Gee HY; Hong S; Guan KL; Roe JS; Lee H; Kim DW; Park HW
Mol Cancer; 2023 Nov; 22(1):177. PubMed ID: 37932786
[TBL] [Abstract] [Full Text] [Related]
11. Viral Infections and Incidence of Reactivations in chronic Myeloid leukemia Patients.
Aldapt MB; Al-Mashdali AF; Obeidat K; Chandra P; Yassin M
Oncology; 2024; 102(4):380-388. PubMed ID: 37848004
[TBL] [Abstract] [Full Text] [Related]
12. [Recent Advance of Newly Therapy for chronic Myeloid leukemia with
Lai HR; Wu QM; Yang YZ; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1579-1583. PubMed ID: 37846720
[No Abstract] [Full Text] [Related]
13. [Next treatment for TKI-resistant CML].
Takahashi N
Rinsho Ketsueki; 2023; 64(9):981-987. PubMed ID: 37793874
[TBL] [Abstract] [Full Text] [Related]
14. A Case Report of chronic myelogenous leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic leukemia Phenotype: Awareness of a Rare Entity.
Efstathopoulou M; Zoi K; Siakantaris MP; Koumbi D; Zannou A; Triantafyllou EF; Tsourouflis G; Lakiotaki E; Vassilakopoulos TP; Angelopoulou MK
Acta Haematol; 2023; 146(6):531-539. PubMed ID: 37557081
[TBL] [Abstract] [Full Text] [Related]
15. The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure.
Ratajczak B; Przybyłowicz-Chalecka A; Czerwińska-Rybak J; Kanduła Z; Ustaszewski A; Gil L; Lewandowski K; Jarmuż-Szymczak M
Leuk Res; 2023 Sep; 132():107349. PubMed ID: 37393627
[TBL] [Abstract] [Full Text] [Related]
16. Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child.
Aktekin EH; Yazici N; Kozanoğlu İ; Erbay A
Lab Med; 2023 Nov; 54(6):e170-e176. PubMed ID: 37352366
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical significance of clonal evolution in chronic myeloid leukemia].
Ochi Y
Rinsho Ketsueki; 2023; 64(5):369-375. PubMed ID: 37271527
[TBL] [Abstract] [Full Text] [Related]
18. Philadelphia chromosome- positive myelodysplastic syndrome with single lineage dysplasia.
Kumar A; Tilak V; Arora D; Marisha ; Rahul ; Gautam D; Ali A
Cancer Genet; 2023 Aug; 276-277():12-16. PubMed ID: 37267684
[TBL] [Abstract] [Full Text] [Related]
19. First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Balsat M; Alcazer V; Etienne G; Huguet F; Berger M; Cayssials E; Charbonnier A; Escoffre-Barbe M; Johnson-Ansah H; Legros L; Roy L; Delmer A; Ianotto JC; Orvain C; Larosa F; Meunier M; Amé S; Andreoli A; Cony-Makhoul P; Morisset S; Tigaud I; Rea D; Nicolini FE
Leuk Res; 2023 Jul; 130():107308. PubMed ID: 37230027
[TBL] [Abstract] [Full Text] [Related]
20. Estimating prognostic relevant cutoff values for a multiplex PCR detecting bcr::abl1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings.
Hailu S; Kinde S; Cross M; Tsegaye A; Kelemu T; Seifu D; Alemayehu D; Tarekegn A; Jabessa G; Abeje D; Abebe M; Sherif A; Tadesse F; Platzbecker U; Howe R; Gebremedhin A
Ann Hematol; 2023 Jul; 102(7):1723-1729. PubMed ID: 37212909
[TBL] [Abstract] [Full Text] [Related]
[Next]
